Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,403
Closed -$872K 384
2021
Q1
$872K Hold
13,403
0.02% 245
2020
Q4
$736K Sell
13,403
-39,750
-75% -$2.03M 0.02% 253
2020
Q3
$2.34M Sell
53,153
-18,612
-26% -$818K 0.05% 219
2020
Q2
$2.85M Hold
71,765
0.1% 164
2020
Q1
$2.85M Buy
71,765
+781
+1% +$33K 0.1% 163
2019
Q4
$3.17M Buy
70,984
+1,790
+3% +$68.8K 0.08% 185
2019
Q3
$2.37M Hold
69,194
0.05% 227
2019
Q2
$2.6M Buy
69,194
+30,794
+80% +$1.05M 0.06% 222
2019
Q1
$1.17M Buy
+38,400
New +$1.17M 0.03% 374

Other funds holding ACA

Barings's ACA Position: Q2 2021 in Review

Barings sold out of Arcosa (ACA) in Q2 2021, closing a stake of 13,403 shares — an estimated $872K sold.

Barings first reported a position in ACA in Q1 2019 and held it in 9 quarters. The position peaked at $3.17M in Q4 2019. 247 funds tracked by Wall St. Rank hold ACA as of Q2 2021.

  • Barings reported no remaining Arcosa position as of Q2 2021 after selling out during the quarter.
  • Barings sold 13,403 Arcosa shares in Q2 2021, an estimated $872K.
  • Barings first reported a position in Arcosa in Q1 2019 and held it in 9 quarters.
  • Barings's Arcosa position peaked at $3.17M in Q4 2019.
  • 247 funds tracked by Wall St. Rank held Arcosa as of Q2 2021.

Based on Barings's 13F filing for Q2 2021, filed 11 Aug 2021.